Gary Finnegan

Deal paves the way for outcomes-based drug pricing

An agreement between the pharma industry and health care providers in Manchester will collect real-world data on the value of drugs. The aim is to open the door to fixing drug prices based on how effective they are in everyday use

EMPTY

A series of pilot projects will use patient outcomes to inform funding decisions, initiating a move from activity-based to value-based healthcare